Cellectis to Participate in Upcoming Investor Conferences
September 02, 2020 16:56 ET
|
Cellectis Inc.
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited...